A detailed history of Concentrum Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Concentrum Wealth Management holds 722 shares of AMGN stock, worth $212,650. This represents 0.09% of its overall portfolio holdings.

Number of Shares
722
Previous 714 1.12%
Holding current value
$212,650
Previous $223 Million 4.28%
% of portfolio
0.09%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $2,475 - $2,699
8 Added 1.12%
722 $233 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $1,051 - $1,277
-4 Reduced 0.56%
714 $223 Million
Q1 2024

May 06, 2024

BUY
$268.87 - $324.56 $5,646 - $6,815
21 Added 3.01%
718 $204 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $178,222 - $201,056
697 New
697 $201 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Concentrum Wealth Management Portfolio

Follow Concentrum Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentrum Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Concentrum Wealth Management with notifications on news.